 |
Recombinant Human soluble Fc-gamma Receptor IIb |
|---|---|
| Trade Name | |
| Orphan Indication | Idiopathic thrombocytopenic purpura |
| USA Market Approval | USA |
| USA Designation Date | 2010-03-22 00:00:00 |
| Sponsor | Baxalta US Inc., now part of Shire Plc;650 Kendall Street;Cambridge, Massachusetts, 02142 |
